Jorge P. Leguizamo

A phase I study of 9-aminocamptothecin as a colloidal dispersion formulation given as a fortnightly 72-h infusion

C. Takimoto, J. Grem, W. Dahut, 2003, Cancer Chemotherapy and Pharmacology.

A Phase I Pharmacologic and Pharmacogenetic Trial of Sequential 24-Hour Infusion of Irinotecan Followed by Leucovorin and a 48-Hour Infusion of Fluorouracil in Adult Patients with Solid Tumors

E. Szabo, J. Grem, G. Leonard, 2005, Clinical Cancer Research.

APhase IPharmacologic and PharmacogeneticTrial of Sequential 24-Hour Infusion of Irinotecan Followedby Leucovorin and a 48-Hour Infusion of Fluorouracil in Adult Patients with SolidTumors

E. Szabo, J. Grem, G. Leonard, 2005 .

Treatment preference and quality of life impact: ravulizumab vs eculizumab for atypical hemolytic uremic syndrome.

T. Symonds, B. Dixon, Shruti Chaturvedi, 2023, Journal of comparative effectiveness research.